Skip to content
Methodology
All entries for: Alembic Pharmaceuticals Inc.
July 31, 2025
Alembic Pharmaceuticals Inc.
Orphan Drug Designation
FDA orphan drug designation: treatment of pachyonychia congenita
Disease Area:
Rare Diseases
Source
Scroll to Top